GSK has agreed to acquire RAPT Therapeutics in a transaction valued at approximately $2.2 billion, adding ozureprubart, a phase IIb long-acting anti-IgE antibody for food allergy prevention, to its ...
Thales has opened a new cortAIx AI accelerator site in Germany, expanding its global network to five locations and reinforcing its focus on trustworthy AI for critical defence and security systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback